SAREPTA THERAP (AB3A.SG) (AB3A STU) stock market data APIs
€15.4133
-0.58(-3.8%)
as of July 2, 2025
Try our APIs with
free plan!
SAREPTA THERAP (AB3A.SG) Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for AB3A.SG.
Prev. Close
15.4133
Open
14.8348
High
15.4133
Low
14.8348
52 wk Range
14.395-140.6
Market Cap
6 592 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SAREPTA THERAP (AB3A.SG) data using free add-ons & libraries
Get SAREPTA THERAP (AB3A.SG) Fundamental Data
SAREPTA THERAP (AB3A.SG) Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SAREPTA THERAP (AB3A.SG) News
New
Sarepta Therapeutics to Announce First Quarter 2025 Financial Results
CAMBRIDGE, Mass., April 22, 2025--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2025 financial result...
Is Sarepta Therapeutics, Inc. (SRPT) the Most Promising Long-Term Stock According to Analysts?
We recently published a list of the 11 Most Promising Long-Term Stocks According to Analysts. In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands agai...
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
Shares of gene therapy companies — including Sarepta Therapeutics — got a lift Monday after FDA's Marty Makary laid out his plans. Continue Reading View Comments
Exploring 3 High Growth Tech Stocks In The US Market
Over the last 7 days, the United States market has remained flat, yet it is up 5.7% over the past year with earnings forecasted to grow by 13% annually. In this context of steady growth, identifying h...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
